News

In most women with elevated TSH who did not start treatment, repeat measurement was ≤4.00 mIU/L

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Metformin Recalled …

Recall is for all lots of metformin hydrochloride extended-release tablets 500 mg from Apotex

Insulin infusion may reduce risk for severe disease in those with hyperglycemia and COVID-19

Prevalence of edentulism, severe tooth loss ≥50 percent higher for adults with RA, asthma, diabetes

Benefit will be voluntary; Medicare recipients must pick an insurance plan that provides it

Higher risk for type 2 diabetes during young adult years tied to body mass index during adolescence

Women who never achieve pregnancy have increased odds of T2DM versus ever-pregnant women with loss

Insulin usage linked to poor prognosis; ACEI/ARB use did not impact clinical outcome in those with HTN

Similar associations found for hypertension, diabetes in large multinational cohort study